Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Stonehouse Jon P
Relationship:   Director
City:   Birmingham
State:   AL
   
Insider Summary:
  
   
Companies Owned :   2    
Direct Shares   1,331,856    

Indirect Shares

  40,000      
Direct Value   $7,278,094    

Indirect Value

  $257,600      
Total Shares   1,371,856      
Total Value   $7,535,694      


Biocryst Pharmaceuticals Inc
 $7,262,839 Bellicum Pharmaceuticals, Inc
 $15,255 Biocryst Pharmaceuticals Inc
 $7,262,839 Bellicum Pharmaceuticals, Inc
 $15,255
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    1   
    0    

     Stock price went up :

    1   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   1.0   
   0.0   
     Percentage Gain/Loss :
   16.7%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Biocryst Pharmaceuticals Inc BCRX President & CEO, Direc... 2024-05-13 1,127,770 2024-05-13 40,000    Premium*  
            Bellicum Pharmaceuticals, Inc BLCM Director 2023-01-03 204,086 2018-11-09 0    Premium*  
* Premium Members only  

Records found :    80         Free Registration Required For Full Results.    Limit: 25

Download
  Page 4 of 4
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
BCRX Biocryst Pharmaceuticals ... President & CEO   •       •      –    2023-12-14 4 D $6.43 $87,397 D/D (13,592) 1,128,859 0 -
BCRX Biocryst Pharmaceuticals ... President & CEO   •       •      –    2023-12-19 4 D $6.05 $85,238 D/D (14,089) 1,114,770 0 -
BCRX Biocryst Pharmaceuticals ... President & CEO   •       •      –    2024-01-03 4 GD $0.00 $0 D/D 20,000 1,094,770 0 -
BCRX Biocryst Pharmaceuticals ... President & CEO   •       •      –    2024-01-03 4 GA $0.00 $0 I/I 20,000 20,000 0 -
BCRX Biocryst Pharmaceuticals ... President & CEO   •       •      –    2024-05-13 4 B $5.55 $166,500 D/D 30,000 1,127,770 2.81 %

  80  Records found
  1   2   3   4     
  Page 4 of 4  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed